Anticancer agents of the anthracyclin family
US9217008B1 · kind B1 · utility
2Cited by
0References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 10, 2014 |
| Grant date | Dec 22, 2015 |
| Priority date | — |
| Expiry date | Jul 10, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07H15/252
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Anthracyclin compounds of the general structure:are disclosed. In these compounds R1 is methyl, acetyl or hydroxyacetyl; R2-R5 and R10-R13 are independently H or methyl; R6 R7 and R8 are independently H, OH or OCH3; and n is zero or one. The compounds are useful for treating cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.